Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Novavax (NVAX) Short term Debt: 2012-2013

Novavax's Short term Debt was N/A to $267,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $267,000, marking a year-over-year change of. This contributed to the annual value of $267,000 for FY2012, which is N/A change from last year.
Per Novavax's latest filing, its Short term Debt stood at $267,000 for Q1 2013, which was down 0.00% from $267,000 recorded in Q4 2012.
In the past 5 years, Novavax's Short term Debt ranged from a high of $769,000 in Q3 2012 and a low of $267,000 during Q4 2012.
For the 2-year period, Novavax's Short term Debt averaged around $434,333, with its median value being $267,000 (2013).